Midazolam in Sodium Chloride NDC 0143-9380

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9380Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9380Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9380-10	00143938010	10 POUCH in 1 CARTON (0143-9380-10) / 1 BAG in 1 POUCH (0143-9380-01) / 100 mL in 1 BAGMarketed from May 19, 2023

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Midazolam in Sodium Chloride
Generic name (nonproprietary): midazolam in sodium chloride
Active ingredients: Midazolam hydrochloride — 1 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Hikma Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216159
Marketing start: May 19, 2023
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 0143-9380_a6be32fe-dc3d-4ce0-b780-8ba6b4261accSPL ID a6be32fe-dc3d-4ce0-b780-8ba6b4261accSPL set ID 4155a60a-b023-4f4a-acae-7bb8fe9dc0c1RxCUI 2541170, 2541171UNII W7TTW573JJ
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143938010 followed by a unit qualifier and the quantity

Package 00143-9380-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 7, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Midazolam in sodium chloride injection is indicated: Continuous intravenous infusion for sedation of intubated and mechanically ventilated adult, pediatric, and neonatal patients as a component of anesthesia or during treatment in a critical care setting. Midazolam in sodium chloride injection is a benzodiazepine indicated for: continuous intravenous infusion for sedation of intubated and mechanically ventilated adult, pediatric, and neonatal patients as a component of anesthesia or during treatment in a critical care setting. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216159

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216159
Product	Strength	Form · route	Labeler	Product NDC
Midazolam in Sodium Chloride	Midazolam hydrochloride 1 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9379